BrandonMatthewHayes-LattinMD
Hematology • Portland, ORHematologic Oncology
Professor of Medicine, Medical Director of Hematology and Medical Oncology
Dr. Hayes-Lattin is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 Sw Sam Jackson Park Rd
Mailcode L586
Portland, OR 97239Phone(503) 494-8534
- Is this information wrong?
Education & Training
Oregon Health & Science UniversityFELLOWSHIP
Oregon Health & Science UniversityRESIDENCY
University of Washington School of MedicineMEDICAL_SCHOOL- StanfordOTHER_TRAINING
Certifications & Licensure
OR State Medical License 1998 - 2021- American Board of Internal Medicine Hematology
Clinical Trials
- Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2009 Jun 01Hayes-Lattin, B.
- Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation Start of enrollment: 2007 Aug 01Afessa, B.,Hayes-Lattin, B.,McClune, B.,Madtes, D.,Stadtmann, E.,Yanik, G.,Long, G.,Lazarus, H.,Castro-Malaspina, H.,Jansen, J.s.,Bolanos-Meade, J.,Schwartz, J.,Wingard, J.,Giralt, S.,Ho, V.
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Jun 01Hayes-Lattin, B.M.
- Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy Start of enrollment: 2005 Jan 01Hayes-Lattin, B.M.
- Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01Perrault-Gray, A.,Ayala, A.,Mohrbacher, A.,Freedman, A.,Grant, A.,Hayes-Lattin, B.,Wood, C.,Redfern, C.,Aboulafia, D.M.,Flinn, I.W.,Chang, J.,Castro, J.E.,Lucas, J.B.,Zhang, J.,Stephenson, J.J.,Martin, J....
Publications & Presentations
PubMed
- Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.Lachowiez, C.,Cook, R. J.,Hayes-Lattin, B.,Maziarz, R. T.,Borate, U.,Traer, E.,Leonard, J.,Newell, L.,Dao, K. H.,Meyers, G.> ;Hematol Oncol Stem Cell Ther. 2019 Mar 06
- RE: A reappraisal of sex-specific cancer survival trends among adolescents and young adults in the United States.Siegel, S. E.,Coccia, P. F.,Barr, R.,Hayes-Lattin, B.,Bleyer, A.> ;J. Natl. Cancer Inst.. 2019 Feb 23
- Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.Pulsipher, M. A., Logan, B. R., Kiefer, D. M., Chitphakdithai, P., Riches, M. L., Rizzo, J. D., Anderlini, P., Leitman, S. F., Varni, J. W., Kobusingye, H., Besser, R....> ;Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Jan 4
- Join now to see all
Press Mentions
Raising Awareness of the Financial Impact of Cancer on Young Adult SurvivorsJuly 10, 2018
How to Help Young Patients Preserve Their FertilityAugust 10, 2017
'I Didn't Know Who I Was Anymore': Cancer's Social Stress Hits Young Adults HardApril 12, 2017- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
